Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2020

Results of Annual General Meeting

19 November 2020 by Audrey Thomson

Results of Annual General Meeting

Categories 2020, ASX Announcements

Presentation to Annual General Meeting

19 November 2020 by Audrey Thomson

Presentation to Annual General Meeting

Categories 2020, ASX Announcements

Report on Activities for the Quarter ended 30 September 2020

30 October 2020 by Audrey Thomson

Report on Activities for the Quarter ended 30 September 2020

Categories 2020, ASX Announcements

Quarterly Report 30 September 2020

30 October 2020 by Audrey Thomson

Quarterly Report 30 September 2020

Categories 2020, ASX Announcements, Quarterly Reports

BIT225 HIV-1 Immunomodulatory Paper Published

15 October 2020 by Audrey Thomson

BIT225 HIV-1 Immunomodulatory Paper Published

Categories 2020, ASX Announcements

Presentation to Investors

15 October 202014 October 2020 by Audrey Thomson

Presentation to Investors

Categories 2020, ASX Announcements

Annual Report and Notice of AGM

9 October 2020 by Audrey Thomson

Annual Report and Notice of AGM

Categories 2020, ASX Announcements

Biotron Compounds Show Activity Against SARS-CoV-2 Virus in Preliminary Assays

7 September 2020 by Audrey Thomson

Biotron Compounds Show Activity Against SARS-CoV-2 Virus in Preliminary Assays

Categories 2020, ASX Announcements

Year End Accounts and Preliminary Final Report

27 August 2020 by Audrey Thomson

Year End Accounts and Preliminary Final Report

Categories 2020, ASX Announcements

Appendix 4G and Corporate Governance Statement

27 August 2020 by Audrey Thomson

Appendix 4G and Corporate Governance Statement 2020

Categories 2020, ASX Announcements
Post navigation
Older posts
Page1 Page2 Page3 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 30 May 2022        Legal Notices and Privacy